Background: Determining which babies should receive antibiotics for potential early onset sepsis (EOS) is challenging. We performed a meta-analysis quantifying how many EOS cases might be 'missed' using the Kaiser Permanente electronic calculator, compared with National Institute for Health and Care Excellence (NICE) guidelines. Methods: A systematic literature search was carried out for studies citing the article in which the calculator was publicised. Studies were eligible if they presented data evaluating the calculator, either by retrospective case review or prospective cohort study. The primary outcome measure was numbers of culture positive EOS cases where the calculator did not recommend empirical antibiotics, but NICE guidelines would have. Data were pooled using a random effect meta-analysis. A subgroup analysis was performed using data from studies of babies exposed to chorioamnionitis. Findings: Eleven studies were included. There were a total of 75 EOS cases across the studies and a minimum of 14 (best case scenario), and a maximum of 22 (worst case scenario) cases where use of the calculator would have resulted in delayed or missed treatment, compared to if NICE guidelines had been followed. The probability of missed/delayed treatment for an EOS case were best case 0.19 [95% confidence intervals 0.11 À 0.29], worst case 0.31 [95% CI 0.17 À 0.49]. The probability of missing cases was significantly more in babies exposed to chorioamnionitis Interpretation: A large proportion of EOS cases were 'missed' by the calculator. Further evaluation of the calculator is recommended before it is introduced into UK clinical practice. Funding: None.
Introduction
Early onset neonatal sepsis (EOS) is defined as infection occurring within 72 h of birth. Babies with EOS may be asymptomatic initially, whilst non-infective pathology can mimic EOS; determining who should receive antibiotics is challenging. In the UK, babies are treated based on risk factors and clinical indicators (see Tables 1 and 2) as defined by the National Institute for Health and Care Excellence (NICE) [1] .
Neonatal antibiotic administration has been reported to be associated with pain, parental anxiety and separation, and in childhood: asthma, allergy and autoimmune disease [2] , as well as presenting significant workload and financial cost.
An electronic risk calculator has been developed by Kaiser Permanente (KP), for babies born 34 weeks gestation, to aid decision making when considering EOS. It is available online: https://neonatal sepsiscalculator.kaiserpermanente.org/InfectionProbabilityCalcula tor.aspx.
In a high-profile paper published in JAMA Pediatrics it was shown to reduce empirical antibiotic use substantially [3] . The calculator contains the following fields: background EOS incidence, gestational age, highest maternal antepartum temperature, rupture of membranes in hours, maternal GBS status and type/timing of intrapartum antibiotics. Clinical presentation is factored in, which adjusts the 'at birth' recommendation given by the calculator. Empirical antibiotics are recommended when the risk is 3/1000 births, or a blood culture and observation if the risk is 1/1000 live births.
The use of a calculator as part of a strategy of managing neonatal EOS adds an objective element to the decision to give or withhold antibiotics. It is vital that the calculator is thoroughly evaluated; it provides an exciting opportunity to provide tailored treatment, but because EOS is rare, it could take substantial time before any additional 'missed' cases of EOS became apparent. In addition, we should be cautious when extrapolating results between countries, because of differences in the EOS incidence and in healthcare practices (e.g. national screening programmes for GBS). Given the impressive reduction in antibiotic usage which has been demonstrated [3] , we wanted to investigate whether this might be at the expense of delaying or missing treatment for some babies with true sepsis.
The aim of this meta-analysis was to pool all the data for available studies of the calculator, to determine the proportion of babies with culture proven EOS which would have been treated using NICE guidelines but were not identified as requiring empiric antibiotics by the calculator.
Methods

Search strategy and selection criteria
We carried out a systematic review and meta-analysis of the sensitivity of the KP EOS calculator, in studies where it was either implemented or compared theoretically to standard practice.
Eligibility criteria
Any studies using the calculator in babies which reported the number of cases of EOS in the study period were eligible for inclusion.
No studies prior to 2011 (when the calculator was first described [4] ) were included. Papers where there were no cases of EOS in the study period were excluded, as uninformative to the sensitivity calculation. Individual patient level data was sought. Review articles and commentaries, where no new data were presented, were excluded. Only one report of each cohort was included. No language limits were applied.
Outcome measures
The proportion of cases of EOS which would have been 'missed', or where treatment would have been delayed by using the calculator, were compared to NICE guidelines. We considered any baby with positive blood cultures and an EOS risk score of <3/1000 as being a 'miss' only if the NICE guidelines would have recommended treatment (as per Tables 1 and 2 ). Any cases where treatment was not recommended by the calculator, but this was concordant with NICE guidelines, were not classified as a 'miss'.
Search
The search was carried out by two authors independently (KJP/ KM), using a modified cluster technique, snowballing from studies citing the 2017 JAMA pediatrics paper [3] . Citing articles were sought on Ovid MEDLINE(R) and Epub Ahead of Print 
Implications of all the available evidence
Whilst antibiotic use was reduced in all included studies, a large proportion of EOS cases are 'missed' by the calculator, additional to cases which would be missed by current guidelines. Clinicians known to be using the calculator were contacted and asked to share data.
Study selection
Once duplicates were removed, the abstracts of all the articles from the search were reviewed independently by two authors (KP and KM), discussing any differences. A third was available for resolution, if required.
Data analysis
The number of EOS cases in each study period and the number of those which were 'missed' or where treatment was delayed when compared to NICE guidelines (as per Tables 1 and 2 ) was recorded, using the study authors' calculation of risk based on their local baseline rate of infection (note that this varied between studies). Where there was uncertainty about whether a case would be 'missed' or not, the authors were contacted for further details and clarification. A sensitivity analysis was undertaken.
Data items
Where possible, we collected the following data from included studies:
Number of babies in the sample Location Date of data collection Organism grown Clinical condition at birth (well, equivocal or ill by KP standards) Gestational age Highest maternal temperature Maternal GBS status Duration of membrane rupture Maternal antibiotics EOS risk at birth and after examinationRisk of bias across studies The risk of bias across studies ("publication bias") was not statistically assessed.
Risk of bias in individual studies
The risk of bias was assessed for each included study using QUA-DAS-2 risk of bias assessment tool, see Table 3 and Supplementary table S2.
Subgroup analyses
There has been discussion in the literature about the use of the calculator amongst higher-risk groups of babies, specifically, babies exposed to chorioamnionitis [5, 6] . We therefore performed a subgroup analysis of all papers focussed on chorioamnionitis exposed babies.
Sensitivity analyses
Determining which cases were missed by the calculator compared to NICE guidelines, presented some challenges. Maternal fever may prompt a clinical team to commence parenteral antibiotics for possible maternal sepsis/chorioamnionitis. Parenteral antibiotics given up to 24 h after birth are a red flag for neonatal sepsis, but maternal fever in isolation is not an indicator for neonatal antibiotics [1] . If papers did not specify whether a mother was being treated for possible sepsis or chorioamnionitis, it was not possible to say whether the baby would have been treated according to NICE guidelines. Dr Kuzniewicz advised that when in doubt, they would classify a high maternal temperature as potential sepsis, in order to give a conservative evaluation of the calculator.
For completion, we performed two meta-analyses, a 'worst case' scenario where uncertain cases were recorded as a 'miss', and a 'best case' scenario where the uncertain cases were treated as if they were not missed.
Summary measures
The principle summary measure is the proportion of delayed/ missed treatment of EOS using the calculator compared to NICE guidelines.
Synthesis of results
The pooled proportion of delayed/missed cases was estimated by a binomial-normal model (rma.glmm) of logit transformed proportions in the metafor package of R. The effect of being in a whole-population cohort vs. a high-infection risk cohort was evaluated as a moderator variable. Heterogeneity between studies was assessed describing I 2 .
Results
Study selection
The initial literature search produced 144 papers, see Fig. 1 . Duplicates were removed leaving 90 articles. The Kuzniewicz 2017 article, two articles found on reviewing reference lists and a conference poster were added resulting in 94 papers which were reviewed in detail. No relevant additional papers were found by searching for publications from the authors of Puopolo 2011 [4] . 15 studies were reviewed in depth. One study was excluded because there were no cases of EOS [7] ; a further was excluded as no information on the number of EOS cases was provided [8] . One study was excluded as it was not possible to extract individual patient level data [9] . A further study was excluded as it was not possible to determine whether the participants were started on antibiotics due to strict adherence to guidelines [10] . 11 studies met the inclusion criteria.
Study characteristics
The studies are summarised in [17] were comparing retrospectively and theoretically how many babies would have been recommended treatment in a subset of babies born to mothers with confirmed or suspected chorioamnionitis.
Joshi 2019 was a quality improvement project mainly relating to serial physical examinations as an alternative method to manage babies exposed to chorioamnionitis [18] . It was eligible for inclusion because the authors had compared their results to those which might have been achieved using the calculator and presented data on the number of EOS cases. Goel 2019 was a prospective cohort study comparing the calculator against NICE guidelines. All babies were managed according to NICE guidelines, and the calculator recommendations were not acted upon [19] .
Stipelman 2019 was a 2 phased quality improvement project, designed to improve uptake of the calculator in their centre [20] . There was sufficient data to incorporate it into the meta-analysis.
Results of individual studies
See and Supplementary Table S1 À data extracted from articles, excluding contaminants. immediate antibiotics. However, a clinician using national guidelines could have been more conservative and treated the baby empirically in case of possible maternal sepsis. The interpretation of such findings is not clearly described and may be a source of potential bias.
Risk of bias across studies
Dhudasia 2018 is the only paper which explains exactly how the "at birth" and "after examination" scores were acted upon; nursing staff calculated the risk at birth for every baby, and if it was > 0.7/ 1000 then the paediatrician was alerted, and the baby examined.
No clear evidence of publication bias was noted.
Synthesis of results
Across the studies there were 75 cases of culture proven EOS. There was a minimum of 14 (best case scenario), and a maximum of 22 (worst case scenario), cases of EOS where the calculator did not recommend empirical antibiotics, i.e. they would have been/were initially 'missed' compared to NICE guidelines, see supplementary table  S3 .
The pooled probability of missing a case of EOS, which would not have been missed by the NICE guidelines, were best case 0.19 [95% confidence interval (CI) 0.11À0.29, I
2 0%] (see Fig. 2 2 0%] (see Fig. 7 ) (test for subgroup difference, p = 0.03).
Discussion
This systematic review and meta-analysis has demonstrated that, compared to the NICE guidelines the probability of the calculator missing a case of EOS were best case 0. 19 Some studies were retrospective, but since they were using contemporaneous notes, there is a limit to the effect this could have had. The intervention, the KP EOS calculator, was the same across the studies. The outcome was well defined and consistent: was the EOS score greater or less than 3/1000 births.
Compared to current guidance, the calculator failed to recommend treatment in at least 14/75 babies with EOS (and possibly up to 22 babies) who would have been treated using NICE guidelines. This is in addition to any babies who will inevitably be missed by the NICE guidelines. The baby with E.coli, for example, in Stipelman 2019 [20] had an isolated temperature of >38°C, which would not trigger treatment based on NICE guidelines, however the clinician decided to commence antibiotics. The EOS score was <3/1000 and so the calculator would also not have recommended treatment and would have missed this case.
The impressive reduction in the use of antibiotics which can be achieved with the calculator can be seen in Table 3 , e.g. from 5% to 2.6% in Kuzniewicz et al. [3] , or in babies exposed to chorioamnionitis one paper demonstrated a potential reduction from 99.7% to 2.5% [17] . However, given the low sensitivity we have demonstrated, we believe that the risks of introducing this tool do not outweigh the benefits. Potential delays in antibiotic administration by using the calculator have been highlighted previously, in a letter to JAMA pediatrics by Rajbhandari et al. [21] . This was rebutted by Kuzniewicz and colleagues, explaining that any potential delays in treatment are far outweighed by the dramatic reduction in antibiotics which they have achieved [22] .
Difference in microbiology and in healthcare practices between the UK and the USA are significant in this context. In the UK for example, GBS screening is not routine, observation nurseries (as described by Money et al.) are not common, prolonged stays on post-natal wards for babies not receiving antibiotics are unusual, and paediatricians are unlikely to ever encounter the majority of babies, as most care is delivered by midwives. When the EOS calculation is low risk, the calculator recommends "routine vitals". However, the majority of UK babies would not have routine observations carried out at all, unless there was clinical concern.
Kuzniewicz et al., point out that "if adopting out approach, individual centers must assess local care structures" [3] . If the calculator were to be adopted in the UK, current postnatal care would have to be adapted. For example, if a baby who would have qualified for observations due to one risk factor as per NICE has a low EOS risk score, would they be allowed to go home after 6 h? Clearly, robust local policies would need to be drawn up on exactly how the calculator were to be used.
It is striking that in all the available evidence there were only 75 cases of EOS. Collins et al. demonstrate that effective evaluation of a prediction model would require at least 100 (and possibly 200) external cases, to validate the model [23] . We would suggest this be carried out retrospectively by accumulating a large series of cases of babies evaluated for sepsis (whilst continuing to use NICE guidelines) rather than rolling out the calculator and potentially missing further cases of EOS.
We have not carried out a corresponding meta-analysis to determine the number of misses that NICE guidelines might have compared to the calculator. Given the broad recommendations for antibiotic use in the NICE guidelines, this was felt unlikely to be beneficial. This study evaluates the sensitivity of the calculator compared to NICE guidelines. We have not made any assessment of its specificity, or its safety when implemented with a whole-nursery system of newborn care. This study does not make a comprehensive assessment of the overall performance of the calculator, rather we have assessed its immediate ability to accurately detect babies who go on to have positive blood cultures.
Whether the benefits of reducing antibiotics use outweigh the occasional 'miss' or delay is hard to quantify, since it is difficult to estimate the effects of widespread (over)use of antibiotics to individuals and populations. This meta-analysis has demonstrated that a large proportion of true cases of EOS are 'missed' by the calculator, in addition to those which would be missed by NICE guidelines. The probability of missing additional cases compared to the NICE guidelines is significantly higher amongst babies exposed to chorioamnionitis.
Given these concerns, further analyses of known cases of EOS is required to determine what proportion would be initially missed or result in delayed treatment. No method for predicting EOS is perfect, and there is no substitute for clinical monitoring, since there will almost inevitably be some babies without risk factors for infection who nevertheless go onto to become septic. Effective evaluation will need approximately 100 cases of EOS to have occurred, a threshold not yet reached in the available literature.
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